FDA NDC
Phesgo
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 50242-260
- Proprietary name
- Phesgo
- Nonproprietary name
- pertuzumab, trastuzumab, and hyaluronidase-zzxf
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, SOLUTION
- Strength
- 600 mg/10mL
HCPCS J2777 Billable units per 11-digit NDC: 60.